metricas
covid
Buscar en
Gastroenterología y Hepatología
Toda la web
Inicio Gastroenterología y Hepatología The impact of anxiety and depression on quality of life in a cohort of inflammat...
Journal Information
Share
Share
Download PDF
More article options
Visits
23
Original Article
Available online 22 November 2024
The impact of anxiety and depression on quality of life in a cohort of inflammatory bowel disease patients from Northeastern of Brazil
Impacto de la ansiedad y la depresión en la calidad de vida en una cohorte de pacientes con enfermedad inflamatoria intestinal en el nordeste de Brasil
Visits
23
Raiza Lima Silvaa, Francisca Isabelle da Silva e Sousaa, Gabriel Lucas Ferreira da Silvaa, Victória Danielly Rabelo Almeidaa, Simão Barbosa Silvaa, Mateus Mendes Santos Freirea, Marcellus Henrique Loiola Ponte de Souzab, Lucia Libanez Bessa Campelo Bragab,
Corresponding author
lucialib@terra.com.br

Corresponding author.
a School of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil
b Department of Internal Medicine, Federal University of Ceará, Walter Cantídio University Hospital, Fortaleza, CE, Brazil
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (4)
Table 1. Comparison of clinical and sociodemographic variables between patients with and without anxiety and depression.
Table 2. Comparisons of averages of IBDQ domains in in IBD patients with and without anxiety and depression.
Table 3. Association between of assessed parameters and the presence of anxiety in IBD patients.
Table 4. Association between of assessed parameters and the presence of depression in IBD patients.
Show moreShow less
Abstract
Objective

This study aims to assess whether the association between chronic pathologies and depressive and/or anxious disorders is high, resulting in a reduction in the patient's quality of life.

Patients and methods

This is a prospective cross-sectional study with a descriptive and analytical design. Sociodemographic data and lifestyle habits were collected. Subsequently, the Inflammatory Bowel Disease Questionnaire (IBDQ) and the Hospital Anxiety and Depression Scale (HADS) were applied.

Results

A total of 141 patients participated in the study, with a mean age of 45.78 (SD 16.01) years, of which 60.3% were female (n=85) and 39.7% were male (n=56). 58.9% had ulcerative colitis (UC) (n=83), and 41.1% had Crohn's disease (CD) (n=58). 16.5% of patients had a previous diagnosis of generalized anxiety disorder (GAD) and/or major depression (MD) (n=23). Regarding IBDQ scores, participants with anxiety had significantly lower mean scores in all IBDQ items (p<0.001), while the depression diagnosis obtained significantly lower mean values for systemic (p=0.015), emotional (p=0.001), and intestinal symptoms (p=0.005).

Conclusion

The results indicate that anxiety and depression negatively impact the quality of life of patients with IBD independently of the disease activity.

Keywords:
Anxiety
Depression
Inflammatory bowel disease
Resumen
Objetivo

El presente estudio tiene como objetivo evaluar si la asociación entre patologías crónicas y trastornos depresivos y/o ansiosos es alta, resultando en una reducción de la calidad de vida del paciente.

Pacientes y métodos

Se trata de un estudio prospectivo transversal con un diseño descriptivo y analítico. Se recogieron datos sociodemográficos y hábitos de vida. Posteriormente se aplicaron el Cuestionario de Enfermedad Inflamatoria Intestinal (IBDQ) y la Escala Hospitalaria de Ansiedad y Depresión (HADS).

Resultados

Participaron en el estudio 141 pacientes, con una edad media de 45,78 (DE 16,01) años, de los cuales el 60,3% eran mujeres (n=85) y el 39,7% varones (n=56). La mayoría padecían colitis ulcerosa (CU) (n=83 [58,9%]), y el 41,1% enfermedad de Crohn (EC) (n=58). El 16,5% de los pacientes tenían un diagnóstico previo de trastorno de ansiedad generalizada (TAG) y/o depresión mayor (DM) (n=23). En cuanto a las puntuaciones del IBDQ, los participantes con ansiedad presentaron puntuaciones medias significativamente inferiores en todos los ítems del IBDQ (p<0,001), mientras que el diagnóstico de depresión obtuvo valores medios significativamente inferiores para los síntomas sistémicos (p=0,015), emocionales (p=0,001) e intestinales (p=0,005).

Conclusión

Los resultados indican que la ansiedad y la depresión afectan negativamente a la calidad de vida de los pacientes con enfermedad inflamatoria intestinal, independientemente de la actividad de la enfermedad.

Palabras clave:
Ansiedad
Depresión
Enfermedad inflamatoria intestinal

Article

These are the options to access the full texts of the publication Gastroenterología y Hepatología
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Gastroenterología y Hepatología

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.gastrohep.2023.01.003
No mostrar más